Clostridium difficile infection in children

Clinical Microbiology Newsletter

Volumn 21, Issue 7, 1999, Pages 49-53

  McGowan, K L ^a   Kader, H A ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANION EXCHANGE RESIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; COLESTYRAMINE; CYTOTOXIN; ENTEROTOXIN; IMMUNOGLOBULIN A; METRONIDAZOLE; NEUROKININ; RECEPTOR; VANCOMYCIN; VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BREAST FEEDING; BREAST MILK; CLOSTRIDIUM DIFFICILE; COLITIS; COST EFFECTIVENESS ANALYSIS; DEHYDRATION; DIARRHEA; DRUG ABSORPTION; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL SYMPTOM; HUMAN; LACTOBACILLUS; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; RECEPTOR BINDING; RELAPSE; REVIEW; SACCHAROMYCES BOULARDII; SYMPTOMATOLOGY;

EID: 0033119734     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(99)80016-6     Document Type: Review

References (36)

1. Clostridium difficile G. Peter 24th ed. American Academy of Pediatrics Red Book: Report of the Committee on Infectious Diseases 1997 American Academy of Pediatrics Elk Grove Village, IL 177 178
2. S.J. Qualman Clostridium difficile invasion and toxin circulation in fatal pediatric pseudomembranous colitis Am. J. Clin. Pathol. 94 1990 410 416
3. D.M. Lyerly H.C. Krivan T.D. Wilkins Clostridium difficile : its disease and toxins Clin. Microbiol. Rev. 1 1988 1 18
4. D.F.M. Thomas Enterocolitis in Hirshsprung's disease: a controlled study of the etiologic role of Clostridium difficile J. Pediatr. Surg. 21 1986 22 25
5. D.F.M. Thomas Association between Clostridium difficile and enterocolitis in Hirschsprung's disease Lancet i 1982 78 79
6. S.P. Hardy R. Bayston L. Spitz Prolonged carriage of Clostridium difficile in Hirschsprung's disease Arch. Dis. Child. 69 1993 221 224
7. R. Whitehead Primary inflammatory disorders and disturbances of digestive function R. Whitehead 2nd ed. Gastrointestinal and Esophageal Pathology 1995 Churchill Livingstone New York 614 616
8. S. Whittier Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile -associated diseases J. Clin. Microbiol. 31 1994 2861 2865
9. G.V. Doern R.T. Coughlin L. Wu Laboratory diagnosis of Clostridium difficile -associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays J. Clin. Microbiol. 30 1992 2042 2046
10. A.B. Onderdonk S.D. Allen Clostridium P.R. Murray 6th ed. Manual of Clinical Microbiology 1995 ASM Press Washington, DC 580 581
11. I. Castagliuolo Neurokinin-1 (NK-1) receptor is required in Clostridium difficile -induced enteritis J. Clin. Invest. 101 1998 1547 1550
12. E Chaves-Olarte Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells J. Clin. Invest. 100 1997 1734 1741
13. R.D. Mitty T. LaMont Pseudomembranous colitis W.A. Walker 2nd ed. Pediatric Gastroenterointestinal Disease: Pathophysiology,Diagnosis, Management 1 1996 Mosby Philadelphia 726 739
14. H.E. Larson Epidemiology of Clostridium difficile in infants J. Infect. Dis. 146 1984 727 733
15. K. Tullus Intestinal colonization with Clostridium difficile in infants up to 18 months of age Eur. J. Clin. Microbiol. and Infect. Dis. 8 1989 390 393
16. A. Collignon Heterogenicity of Clostridium difficile isolates from infants Eur. J. Ped. 152 1993 319 322
17. K. Kim Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence for person-to-person spread J. Peds. 102 1983 376 382
18. A.C. Emeruwa J.U. Oguike Incidence of cytotoxin producing isolates of Clostridium difficile in faeces of neonates and children in Nigeria Microbiologica 13 1990 323 328
19. R.D. Rolfe W. Song Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding J. Med. Microbiol. 42 1995 10 19
20. G. Gonzalez-Valencia O. Munoz J.F. Torres Toxigenicity and adherence in Clostridium difficile strains isolated from patients with and without diarrhoea Arch Invest. Med. 22 1991 189 196
21. S.B. Meropol A.A. Luberti A.R. DeJong Yield from stool testing of pediatric inpatients Arch. Pediatr. Adolesc. Med. 151 1997 142 145
22. S. Wongwanich Clostridium difficile associated disease in Thailand SE Asian J. Trop. Med. and Pub. Health. 21 1990 367 372
23. A. Anand A.E. Glatt Clostridium difficile infection associated with antineoplastic chemotherapy: a review Clin. Infect. Dis. 17 1993 109 113
24. S.S. Burgner A prospective study of Clostridium difficile infection and colonization in pediatric oncology patients Pediatr. Infect. Dis. J. 16 1997 1131 1134
25. C.J. Welkon Clostridium difficile in patients with cystic fibrosis AJDC 139 1985 805 808
26. T.C. Wu V.P. McCarthy V.J. Gill Isolate rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis J. Infect. Dis. 148 1983 176
27. D.N. Gerding J.S. Brazier Optimal methods for identifying Clostridium difficile infections Clin. Infect. Dis. 16 1993 S439 S442 Suppl 4
28. R. Fekety Antibiotic-associated colitis G.L. Mandell 4th ed. Principles and Practice of Infectious Fisease 1995 Churchill Livingstone New York 978 987
29. M. Riegler Clostridium difficile toxin B is more potent than toxin A in damaging human colonic mucosa in vitro Gastroenterology 104 1993 A770
30. M.C. Barc Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo Antimicrob. Agents Chemother. 36 1992 1332 1335
31. H.A. Kader Detection of Clostridium difficile toxins A or B alone will not diagnose all Clostridium difficile diarrhea in pediatric patients Gastroenterology 115 1998 1 7
32. B.A. Lashner Clostridium difficile culture-positive toxin-negative diarrhea Am. J. Gastroenterol. 81 1986 940 943
33. R. Fekety A.B. Shah Diagnosis and treatment of recurrent Clostridium difficile colitis JAMA 269 1993 71 75
34. R.W. Talbot R.C. Walker R.W. Beart Jr. Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis Brit. J. Surg. 73 1986 457 460
35. J.P. Buts G. Corthier M. Delmee Saccharomyces boulardii for Clostridium difficile -associated enteropathies in infants J. Ped. Gastroenterol. and Nutr. 16 1993 419 425
36. S.L. Gorbach T.W. Chang B. Goldin Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG Lancet 2 1987 1519